ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
30 Sep 2019

Acarix offentliggör EU-tillväxtprospekt i samband med företrädesemission om cirka 51,8 MSEK

Pressmeddelande  Malmö, 30 september 2019 Acarix offentliggör EU-tillväxtprospekt i samband med företrädesemission om cirka 51,8 MSEK...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Sep 2019

Acarix publish EU growth prospectus in connection with rights issue of up to approximately SEK 51.8 million

Press release Malmö, 30 September 2019 Acarix publish EU growth prospectus in connection with rights issue of up to approximately SEK...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Prospectus, Regulatory
November 18, 2024
30 Sep 2019

Acarix publish EU growth prospectus in connection with rights issue of up to approximately SEK 51.8 million

Press releaseMalmö, 30 September 2019Acarix publish EU growth prospectus in connection with rights issue of up to approximately SE...
Continue reading
author-avatar acarix
Corporate Action, IR, Listing Regulation, News, Prospectus, Regulatory, Swedish
November 18, 2024
30 Sep 2019

Acarix offentliggör EU-tillväxtprospekt i samband med företrädesemission om cirka 51,8 MSEK

Pressmeddelande Malmö, 30 september 2019Acarix offentliggör EU-tillväxtprospekt i samband med företrädese...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Sep 2019

Acarix genomför företrädesemission om cirka 51,8 MSEK för att finansiera ökad marknadsexpansion

Pressmeddelande  Malmö, 25 september 2019 Acarix genomför företrädesemission om cirka 51,8 MSEK för att finansiera ökad marknadsexpa...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Sep 2019

Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion

Press release  Malmö, 25 September 2019 Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased ...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish
November 18, 2024
25 Sep 2019

Acarix genomför företrädesemission om cirka 51,8 MSEK för att finansiera ökad marknadsexpansion

Pressmeddelande  Malmö, 25 september 2019Acarix genomför företrädesemission om cirka 51,8 MSEK för att fi...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
25 Sep 2019

Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion

Press release  Malmö, 25 September 2019Acarix carries out a rights issue of approximately SEK 51.8 million to finance an incr...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
16 Aug 2019

Announcement from Acarix’s extra general meeting

Press releaseMalmö August 5, 2019Announcement from Acarix's extra general meetingThe extra general meeting ("EGM") of Acarix AB ("...
Continue reading
author-avatar acarix
Press
August 6, 2024
16 Aug 2019

Kommuniké från extra bolagsstämma i Acarix

Press releaseMalmö Augusti 16, 2019 Kommuniké från extra bolagsstämma i Acarix Extra bolagsstämman i Acarix AB ("Acarix" el...
Continue reading
author-avatar acarix
Press
August 6, 2024
16 Aug 2019

Announcement from Acarix’s extra general meeting

Press releaseMalmö August 5, 2019 Announcement from Acarix's extra general meeting The extra general meeting ("EGM") o...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish
November 18, 2024
16 Aug 2019

Kommuniké från extra bolagsstämma i Acarix

Press releaseMalmö Augusti 16, 2019Kommuniké från extra bolagsstämma i AcarixExtra bolagsstämman i Acarix A...
Continue reading
  • «
  • ‹
  • 61
  • 62
  • 63
  • 64
  • 65
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.